InvestorsHub Logo
Followers 0
Posts 63
Boards Moderated 0
Alias Born 04/21/2016

Re: None

Thursday, 11/30/2017 3:48:02 PM

Thursday, November 30, 2017 3:48:02 PM

Post# of 463404
All, here is a response from Clayton Robertson an associate with the The Trout Group LLC which is the IR group for AVXL.

GM Clayton, I recently asked this question at the beginning of November and you had responded that Dr. Missling and team still plan to start the three trials in 2017. I believe the three trials are Rhetts, Parkinson's and ALZ. I is now the end of November or essentially beginning of the last month of 2017 and there has been no news at all. Can you tell me what the current status is? Do they still plan to start all three trials in 2017, or a subset of the three?

His response to me.

That is correct. All three trials to be initiated, guidance hasn't changed.
Out of office today and tomorrow, but can call you next week. Anyone can contact him. I got the response this morning.


Clayton Robertson
Associate

The Trout Group LLC
740 Broadway, 9th Floor
New York, NY 10003

+1 646 378 2964 Direct
+1 646 323 3950 Cell
+1 646 378 2901 Fax
crobertson@troutgroup.com
www.troutgroup.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News